Pzena Investment Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-1,599
| Closed | -$509K | – | 166 |
|
2024
Q2 | $509K | Sell |
1,599
-498
| -24% | -$159K | ﹤0.01% | 142 |
|
2024
Q1 | $482K | Buy |
2,097
+75
| +4% | +$17.2K | ﹤0.01% | 143 |
|
2023
Q4 | $445K | Buy |
2,022
+159
| +9% | +$35K | ﹤0.01% | 152 |
|
2023
Q3 | $421K | Sell |
1,863
-211
| -10% | -$47.7K | ﹤0.01% | 147 |
|
2023
Q2 | $458K | Buy |
2,074
+369
| +22% | +$81.5K | ﹤0.01% | 146 |
|
2023
Q1 | $382K | Buy |
+1,705
| New | +$382K | ﹤0.01% | 150 |
|
2022
Q2 | – | Sell |
-2,768
| Closed | -$497K | – | 178 |
|
2022
Q1 | $497K | Buy |
2,768
+181
| +7% | +$32.5K | ﹤0.01% | 152 |
|
2021
Q4 | $559K | Sell |
2,587
-209
| -7% | -$45.2K | ﹤0.01% | 150 |
|
2021
Q3 | $516K | Buy |
2,796
+500
| +22% | +$92.3K | ﹤0.01% | 150 |
|
2021
Q2 | $412K | Buy |
+2,296
| New | +$412K | ﹤0.01% | 158 |
|
2021
Q1 | – | Sell |
-4,289
| Closed | -$651K | – | 182 |
|
2020
Q4 | $651K | Sell |
4,289
-804
| -16% | -$122K | ﹤0.01% | 147 |
|
2020
Q3 | $514K | Sell |
5,093
-185
| -4% | -$18.7K | ﹤0.01% | 156 |
|
2020
Q2 | $639K | Buy |
+5,278
| New | +$639K | ﹤0.01% | 157 |
|